Fei-fei L. Tang

Beijing Key Laboratory Of Cell And Gene Therapy For Hematologic Malignancies, No. 11 Xizhimen South Street, Xicheng District
Xizhimen, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Clinical characteristics and prognosis of therapy-related acute myeloid leukemia patients with RUNX1::RUNX1T1.

Clinical characteristics and prognosis of therapy-related acute myeloid leukemia patients with RUNX1::RUNX1T1.

Journal: BMC cancer

Published: January 08, 2026

Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insights.

Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insights.

Journal: British journal of haematology

Published: June 10, 2025

Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study.

Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study.

Journal: Bone marrow transplantation

Published: March 05, 2025

N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission--A pilot study.

N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission--A pilot study.

Journal: Cancer letters

Published: January 17, 2025

A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

Journal: British journal of haematology

Published: January 01, 2024

Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.

Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.

Journal: Hematological oncology

Published: October 04, 2023

Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia.

Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia.

Journal: Frontiers in oncology

Published: February 15, 2023

Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.

Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.

Journal: Bone marrow transplantation

Published: December 22, 2022

The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.

The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.

Journal: British journal of haematology

Published: September 17, 2022

Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia.

Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia.

Journal: Bone marrow transplantation

Published: November 04, 2021

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study.

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study.

Journal: Blood

Published: October 28, 2021

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia.

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia.

Journal: Chinese medical journal

Published: October 20, 2021

Showing 1-12 of 46

Last Updated: 09/26/2026